Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Ligands for Target Protein for PROTAC
    (9)
  • Autophagy
    (2)
  • Bcl-2 Family
    (2)
  • Androgen Receptor
    (1)
  • Apoptosis
    (1)
  • BTK
    (1)
  • Epigenetic Reader Domain
    (1)
  • FAK
    (1)
  • FKBP
    (1)
  • FLT
    (1)
Filter
Search Result
Results for "

target protein-binding moiety

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | Inhibitors_Agonists
  • Dye Reagents
    2
    TargetMol | Dye_Reagents
  • PROTAC Products
    10
    TargetMol | PROTAC
Ibrutinib
PCI-32765
T1835936563-96-1
Ibrutinib (PCI-32765) is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Hot
(+)-JQ-1
JQ1
T21101268524-70-4
(+)-JQ-1 (JQ1) is a specific, reversible BET bromine domain inhibitor that targets BRD4 (1 2) with IC50 values of 77 33 nM. (+)-JQ-1 induces cell autophagy and inhibits cell proliferation.
  • $30
In Stock
Size
QTY
AR antagonist 1
T103591818885-54-9
AR antagonist 1 is a potent antagonist of the androgen receptor. It binds to E3 ligase ligands with weak binding affinities to VHL protein in the synthesis of PROTAC ARD-266.
  • $55
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Quizartinib
AC220
T2066950769-58-1
Quizartinib (AC220) is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.
  • $53
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Dasatinib carbaldehyde
PROTAC ABL binding moiety 4, BMS-354825 carbaldehyde
T185952112837-79-1
Dasatinib carbaldehyde (PROTAC ABL binding moiety 4) is based on Dasatinib which is an ABL inhibitor, binds to the IAP ligand via a linker, and forms SNIPER [1].
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Desmorpholinyl Navitoclax-NH-Me
Desmorpholinyl ABT-263-NH-Me, Desmorpholinyl Navitoclax-NH-Me
T399102365172-82-1
Desmorpholinyl Navitoclax-NH-Me (Desmorpholinyl ABT-263-NH-Me) is a Bcl-xL inhibitor, which can be employed alongside a CRBN ligand to synthesize XZ739, a PROTAC BCL-XL degrader [1] [2].
  • $46
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Navitoclax-piperazine
ABT-263-piperazine
T121862143096-93-7
Navitoclax-piperazine (ABT-263-piperazine) is a B-cell lymphoma extra large (BCL-XL) inhibitor.
  • $112
In Stock
Size
QTY
SLF-amido-C2-COOH
PROTAC FKBP12-binding moiety 1
T139141092369-24-8
SLF-amido-C2-COOH (ZZY01-083) is an FKBP ligand with potential antimicrobial activity for the synthesis of PROTAC.
  • $48
In Stock
Size
QTY
DUPA
N,N''-Carbonylbis[L-glutamic acid], (2S,2'S)-2,2'-Carbonylbis(Azanediyl)Dipentanedioic Acid
T19301302941-52-2
DUPA (N,N''-Carbonylbis[L-glutamic acid]) is used as the targeting moiety to actively deliver DTX for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer.
  • $37
In Stock
Size
QTY
TargetMol | Inhibitor Sale
BI-4464
T54801227948-02-8
BI-4464, a highly selective ATP-competitive inhibitor of PTK2 FAK, exhibits an IC50 of 17 nM and serves as a PTK2 ligand for PROTAC (Proteolysis Targeting Chimera).
  • $52
In Stock
Size
QTY